StreetInsider.com News Articles

The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It

Tue, 16 Jun 2026 08:45:00 -0400

Issued on behalf of MindWalk Holdings Corp.

Everyone is racing to point powerful AI models at drug discovery. A growing camp argues the real prize is the layer beneath the models — the connected biological knowledge they reason over — and that is where one Nasdaq-listed company has placed its bet.

NEW YORK, June 16, 2026 /PRNewswire/ -- Equity Insider News Commentary — The story the market has been telling itself about artificial intelligence and drug discovery is, at its core, a story about models. Bigger models, smarter models,

The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It

Tue, 16 Jun 2026 08:45:00 -0400

Issued on behalf of MindWalk Holdings Corp.

The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It

Tue, 16 Jun 2026 08:45:00 -0400

Issued on behalf of MindWalk Holdings Corp.

The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It

Tue, 16 Jun 2026 08:45:00 -0400

Issued on behalf of MindWalk Holdings Corp.

The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It

Tue, 16 Jun 2026 08:45:00 -0400

Issued on behalf of MindWalk Holdings Corp.

The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It

Tue, 16 Jun 2026 08:45:00 -0400

Issued on behalf of MindWalk Holdings Corp.

The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It

Tue, 16 Jun 2026 08:45:00 -0400

Issued on behalf of MindWalk Holdings Corp.

The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It

Tue, 16 Jun 2026 08:45:00 -0400

Issued on behalf of MindWalk Holdings Corp.

The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It

Tue, 16 Jun 2026 08:45:00 -0400

Issued on behalf of MindWalk Holdings Corp.

The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It

Tue, 16 Jun 2026 08:45:00 -0400

Issued on behalf of MindWalk Holdings Corp.

The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It

Tue, 16 Jun 2026 08:45:00 -0400

Issued on behalf of MindWalk Holdings Corp.

The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It

Tue, 16 Jun 2026 08:45:00 -0400

Issued on behalf of MindWalk Holdings Corp.

The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It

Tue, 16 Jun 2026 08:45:00 -0400

Issued on behalf of MindWalk Holdings Corp.

The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It

Tue, 16 Jun 2026 08:45:00 -0400

Issued on behalf of MindWalk Holdings Corp.

The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It

Tue, 16 Jun 2026 08:45:00 -0400

Issued on behalf of MindWalk Holdings Corp.

The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It

Tue, 16 Jun 2026 08:45:00 -0400

Issued on behalf of MindWalk Holdings Corp.

The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It

Tue, 16 Jun 2026 08:45:00 -0400

Issued on behalf of MindWalk Holdings Corp.

The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It

Tue, 16 Jun 2026 08:45:00 -0400

Issued on behalf of MindWalk Holdings Corp.

The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It

Tue, 16 Jun 2026 08:45:00 -0400

Issued on behalf of MindWalk Holdings Corp.

The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It

Tue, 16 Jun 2026 08:45:00 -0400

Issued on behalf of MindWalk Holdings Corp.

Form 4/A Absci Corp For: Jun 04 Filed by: Szela Mary T

Mon, 15 Jun 2026 20:40:00 -0400

si-local-file:///var/storage/secattach/20260615/26649165.html

Form 4/A Absci Corp For: Jun 04 Filed by: Szela Mary T

Mon, 15 Jun 2026 20:40:00 -0400

si-local-file:///var/storage/secattach/20260615/26649165.html

Absci Corp. (ABSI) PT Raised to $15 at Guggenheim

Mon, 15 Jun 2026 06:54:10 -0400

(Updated - June 15, 2026 6:54 AM EDT)

Guggenheim analyst Vamil Divan raised the price target on Absci Corp. (NASDAQ: ABSI) to $15.00 (from $10.00) while maintaining a Buy rating.

The analyst commented: "We are increasing our price target to $15 (from $10) and reiterating our Buy rating on ABSI shares after doing a deeper dive into their lead asset ABS-201 ahead of interim proof of concept data we expect to be released for ABS-201 in 2H 2026. The hair loss market is a large one that we believe is underserved by treatments that currently deliver limited efficacy and/or have concerning side

Absci Corp. (ABSI) PT Raised to $15 at Guggenheim

Mon, 15 Jun 2026 06:54:10 -0400

(Updated - June 15, 2026 6:54 AM EDT)

Guggenheim analyst Vamil Divan raised the price target on Absci Corp. (NASDAQ: ABSI) to $15.00 (from $10.00) while maintaining a Buy rating.

MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery

Fri, 12 Jun 2026 09:00:00 -0400

AUSTIN, Texas--(BUSINESS WIRE)-- MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a bio-native AI company, today announced that President and Chief Executive Officer Dr. Jennifer Bath will join a virtual panel hosted by Jones, alongside Absci (NASDAQ: ABSI) and a leading AI compute provider, as part of Jones AI Day. The panel, “Partnering to Power the New Era of Drug Discovery,” will be held on Monday, June 15, 2026, at 12:00 p.m. ET.

Moderated by Jones Research Senior Research Analysts Dr. Debanjana Chatterjee and Dr. Danya Ben-Hail, the panel will explore how the convergence of high-performance compute, native biological knowledge